Skip to main content
. 2025 Oct 17;18(10):1566. doi: 10.3390/ph18101566
AEs Adverse Events
CIs Confidence Intervals
CKD Chronic Kidney Disease
DD Dialysis-dependent
EPO Erythropoietin
ESAs Erythropoietic-Stimulating Agents
Hb Hemoglobin
HD Hemodialysis
HIF Hypoxia-Inducible Factor
MACEs Major Adverse Cardiovascular Events
NDD Non-dialysis-dependent
OR Odds Ratio
PD Peritoneal Dialysis
PHs Prolyl hydroxylases
SAEs Serious Adverse Events